Parasitemia clinical trials
The registry lists 22 studies for Parasitemia across more than 10 countries. 1 are recruiting or about to start. 5 of them are mainly about Parasitemia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.
Get an email when these change. Save the Parasitemia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
National Institute of Allergy and Infectious Diseases (NIAID) (12) · Medicines for Malaria Venture (3) · UPECLIN HC FM Botucatu Unesp (1) · Ministry of Health, Bhutan (1) · Novartis Pharmaceuticals (1) · Pfizer (1) · University of Rochester (1) · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (1)
What is being tested here
Drugs under test in Parasitemia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Pyronaridine | 0 | 0 | 1 |
| Acetaminophen | 0 | 0 | 1 |
| Ibuprofen | 0 | 0 | 1 |
| NITD 609 | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Nov 2027Induced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Challenge Agent and Evaluate Transmission in Mosquito Feeding Assays · National Institute of Allergy and Infectious Diseases (NIAID)
Who these studies take
Of the 1 Parasitemia studies recruiting now, 0 (0%) set no upper age limit and 1 (100%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (100%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 1 (100%) | 1 (100%) |
| 30 | 1 (100%) | 1 (100%) |
| 40 | 1 (100%) | 1 (100%) |
| 50 | 1 (100%) | 1 (100%) |
| 65 | 0 (0%) | 0 (0%) |
| 75 | 0 (0%) | 0 (0%) |
| 85 | 0 (0%) | 0 (0%) |
Across all 22 studies, recruiting or not: 82% stop at 75 or younger and 82% at 65; 32% take children; 9% are for women only and 0% for men only; 68% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 22 of 22. search them.
- Induced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Challenge Agent and Evaluate Transmission in Mosquito Feeding AssaysRecruitingNCT06607003Phase 11 country
- Plasmodium and Other Parasites in Pregnant Women and Children Around Margibi and Montserrado Counties, LiberiaCompletedNCT037195991 country
- Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. FalciparumCompletedNCT05979207Phase 11 country
- Pyronaridine in Healthy Adult Participants Infected With Blood Stage MalariaCompletedNCT05287893Phase 11 country
- Aggressive Antipyretics for Fever Reduction in CNS MalariaCompletedNCT03399318Phase 22 countries
- Molecular Basis of Erythrocyte Invasion by Plasmodium Vivax Into Duffy-Negative Erythrocytes in MaliCompletedNCT033046911 country
- Blood-Stage Plasmodium Vivax Cell BankCompletedNCT05095272Phase 11 country
- Trial to Evaluate CIS43LS in Healthy AdultsCompletedNCT04206332Phase 11 country
- Study in Blood Stage Malaria Infection After DVI of Cryopreserved P. Falciparum (NF54 Strain) SporozoitesCompletedNCT04310085Phase 11 country
- Dose Escalation PfSPZ-CVacCompletedNCT03083847Phase 11 country
- Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in TanzaniaCompletedNCT02909712Phase 21 country
- Study of Controlled Human Malaria Infections to Evaluate Protection After Intravenous or Intramuscular Administration of PfSPZ Vaccine in Malaria-Naive AdultsCompletedNCT02015091Phase 11 country
- Markers of T Cell Suppression: Antimalarial Treatment and Vaccine Responses in Healthy Malian AdultsCompletedNCT025440481 country
- Comparing PI-Based to a nNRTI-based ART for Clearance of Plasmodium Falciparum Parasitemia in HIV-InfectedCompletedNCT01632891Phase 1/23 countries
- Experimental PfSPZ Vaccine in Adults Without MalariaCompletedNCT01441167Phase 11 country
- Impact of Antimalarial Treatment on Measures of T Cell Suppression/Regulation in Healthy Adults From Doneguebougou, MaliCompletedNCT026595661 country
- Markers of T Cell Suppression: Associations With Malaria Infection and Antimalarial Treatment in Malian ChildrenCompletedNCT025049181 country
- Impact of TMP-SMX Prophylaxis on Malaria Infection and Immunity in Children in UgandaCompletedNCT020945081 country
- A Study to Assess Efficacy, Safety of KAE609 in Adult Patients With Acute Malaria Mono-infectionCompletedNCT01860989Phase 22 countries
- Evaluate Parasitological Clearance Rates And Pharmacokinetics Of The Combination Of Azithromycin And Chloroquine In Asymptomatic Pregnant Women With Falciparum Parasitemia In AfricaTerminatedNCT01103713Phase 35 countries
- Parasitic Clearance and Recurrence Rates Among Patients With Vivax MalariaStatus unknownNCT017843151 country
- Chagas Disease Diagnostic - Inconclusive SerologyCompletedNCT00511589Not applicable1 country